RMD Open · 2026-06-24
Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritis
Phrase rank #1 · DOI 10.1136/rmdopen-2026-006929
Conditions & diseases
disease activity
Observed in 158 articles across 12 journals.
Latest share0.39%
Change vs baseline-0.02 pp
Months observed13
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- Lupus Science & Medicine80
- RMD Open38
- BMJ Open11
- Gut9
- Journal of Scleroderma and Related Disorders8
- BMJ Neurology Open3
- BMJ Open Gastroenterology2
- BMJ Open Sport & Exercise Medicine2
- Journal of Neurology, Neurosurgery & Psychiatry2
- British Journal of Ophthalmology1
- Frontline Gastroenterology1
- Journal of Clinical Pathology1
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
RMD Open · 2026-06-16
Elevated plasma monounsaturated fatty acids and their associations with disease activity, adiposity and sex in patients with rheumatoid arthritis: a cross-sectional study
Phrase rank #1 · DOI 10.1136/rmdopen-2026-006777
RMD Open · 2026-04-28
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
Phrase rank #1 · DOI 10.1136/rmdopen-2025-006593
RMD Open · 2026-03-09
Inflammation response criteria for rheumatoid arthritis based on the two-component disease activity score
Phrase rank #1 · DOI 10.1136/rmdopen-2025-006631
Lupus Science & Medicine · 2026-03-01
PT7:02 Discordance between SLEDAI-2K and BILAG-2004 disease activity classification leads to divergent treatment decisions under EULAR 2023 recommendations: a post-hoc analysis of anifrolumab trials
Phrase rank #1 · DOI 10.1136/lupus-2026-el.72
Lupus Science & Medicine · 2026-03-01
PO:05:125 Remission is associated with better health-related quality of life and work-force participation, with lower fatigue, and better patient-reported disease activity. Data from the almenara lupus cohort
Phrase rank #1 · DOI 10.1136/lupus-2026-el.195
Lupus Science & Medicine · 2026-03-01
PO:07:189 Clinical and immunoserological profile of SLE patients in Serbia: a two-center cohort analysis
Phrase rank #1 · DOI 10.1136/lupus-2026-el.250
Lupus Science & Medicine · 2025-08-14
Disease activity trajectories in paediatric lupus and associations with socioeconomic factors and patient-reported pain
Phrase rank #1 · DOI 10.1136/lupus-2025-001521
RMD Open · 2026-06-29
Measurement properties of instruments assessing peripheral arthritis disease activity in spondyloarthritis: a systematic literature review
Phrase rank #2 · DOI 10.1136/rmdopen-2026-006900
Journal of Scleroderma and Related Disorders · 2026-06-05
P.292 Multifactorial explanatory model of fatigue in patients with systemic sclerosis: a structural equation approach
Phrase rank #2 · DOI 10.1136/JSRD-2026-SSWC.335
Journal of Neurology, Neurosurgery & Psychiatry · 2026-05-14
Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity
Phrase rank #2 · DOI 10.1136/jnnp-2025-337944
BMJ Open Sport & Exercise Medicine · 2026-03-18
High-intensity exercise for maintained health-enhancing physical activity in patients with rheumatoid arthritis: a randomised controlled trial
Phrase rank #2 · DOI 10.1136/bmjsem-2025-002543
Lupus Science & Medicine · 2026-03-12
Serum IL-2 levels are associated with disease activity and related to dyslipidaemia and the immunological profile in systemic lupus erythematosus
Phrase rank #2 · DOI 10.1136/lupus-2025-001870
Lupus Science & Medicine · 2026-03-01
PO:02:042 Serum calprotectin as a marker of disease activity and specific clinical manifestations in systemic lupus erythematosus
Phrase rank #2 · DOI 10.1136/lupus-2026-el.118
Lupus Science & Medicine · 2026-03-01
PO:03:095 Patterns of disease activity and organ damage accrual in systemic lupus erythematosus: insights from a 10-year tertiary care cohort
Phrase rank #2 · DOI 10.1136/lupus-2026-el.169
Lupus Science & Medicine · 2026-03-01
PO:05:150 Treating-to-target (T2T): similar attainment of remission and low disease activity in patients with systemic lupus erythematosus (SLE) and patients with rheumatoid arthritis (RA)
Phrase rank #2 · DOI 10.1136/lupus-2026-el.214
Lupus Science & Medicine · 2026-03-01
S13:02 Advancing arthritis assessment in SLE clinical trials: derivation, validation and proposed thresholds of the lupus arthritis and musculoskeletal disease activity (LAMDA) instrument
Phrase rank #2 · DOI 10.1136/lupus-2026-el.18
Lupus Science & Medicine · 2026-03-01
S7:05 Ability of SLE-DAS and SLEDAI-2K to predict organ damage accrual in SLE: a real-world 7-year cohort study from Sweden
Phrase rank #2 · DOI 10.1136/lupus-2026-el.10
Lupus Science & Medicine · 2026-03-01
PO:05:143 Belimumab is associated with early improvement in disease activity measures among patients with systemic lupus erythematosus in the US
Phrase rank #2 · DOI 10.1136/lupus-2026-el.208
RMD Open · 2026-02-02
Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritis
Phrase rank #2 · DOI 10.1136/rmdopen-2025-006420
Lupus Science & Medicine · 2025-12-23
Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality
Phrase rank #2 · DOI 10.1136/lupus-2025-001766
RMD Open · 2025-10-28
Pre-eclampsia is more common in women with active psoriatic arthritis in pregnancy: a population-based study
Phrase rank #2 · DOI 10.1136/rmdopen-2025-005666
RMD Open · 2025-09-23
Development and validation of LUPIN: a patient-centred self-administered tool to assess disease activity and patient-reported outcomes in systemic lupus erythematosus
Phrase rank #2 · DOI 10.1136/rmdopen-2025-006106
Lupus Science & Medicine · 2026-07-16
Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort
Phrase rank #3 · DOI 10.1136/lupus-2026-002054
RMD Open · 2026-06-24
Long-term safety and efficacy of upadacitinib compared with adalimumab in patients with rheumatoid arthritis: 7-year data from the SELECT-COMPARE study
Phrase rank #3 · DOI 10.1136/rmdopen-2025-006657
Lupus Science & Medicine · 2026-06-17
Mental health monitoring in adolescents with SLE: associations with lupus low disease activity state and remission
Phrase rank #3 · DOI 10.1136/lupus-2026-002034
Journal of Scleroderma and Related Disorders · 2026-06-05
P.213 Comparison of localized scleroderma assessment tools, teletermography and ultrasound in the evaluation of juvenile localized cutaneous scleroderma: preliminary data of a monocentric study
Phrase rank #3 · DOI 10.1136/JSRD-2026-SSWC.257
Lupus Science & Medicine · 2026-03-06
Clinical utility and performance of anti-C1q antibodies for SLE: comparative analysis of three different assays
Phrase rank #3 · DOI 10.1136/lupus-2025-001896
RMD Open · 2026-03-04
Distinct pattern of comorbidities hinders treatment target attainment in SLE through persistent disease activity and delayed glucocorticoid tapering: longitudinal data from a multicentre cohort study
Phrase rank #3 · DOI 10.1136/rmdopen-2025-006424
Lupus Science & Medicine · 2026-03-01
LBA:01:46 Disease activity is associated with worse fatigue and quality of life in systemic lupus erythematosus
Phrase rank #3 · DOI 10.1136/lupus-2026-el.439